Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
US-2024409487-A1 · Dec 12, 2024 · US
Organic emulsion comprising DHA and EPA
US9579301B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9579301-B2 |
| Application number | US-201314371840-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 11, 2013 |
| Priority date | Jan 11, 2012 |
| Publication date | Feb 28, 2017 |
| Grant date | Feb 28, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to an emulsion of an oil composition comprising docasoahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which is characterized in that the emulsion is essentially free from ascorbyl palmitate.
First claim
Opening claim text (preview).
The invention claimed is: 1. An emulsion consisting essentially of: (i) 5-40 wt-%, based on the total weight of the emulsion, of docasoahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) oils, (ii) 3-15 wt-%, based on the total weight of the emulsion, of fish gelatin, (iii) 1-5 wt-%, based on the total weight of the emulsion, of ascorbic acid and/or citric acid, (iv) 0.5-5 wt-%, based on the total weight of the emulsion, of NaOH, (v) 35-90.5 wt-%, based on the total weight of the emulsion, of water, (vii) 150 ppm-1000 ppm of at least one tocopherol, and (vii) 1000 ppm-5000 ppm of rosemary extract, wherein the emulsion is essentially free of ascorbyl palmitate and the pH of the emulsion is between 5 and 7. 2. The emulsion of claim 1 , wherein the emulsion is natural and/or organic. 3. The emulsion of claim 1 , wherein the tocopherol is selected from the group consisting of dl-a-tocopherol, d-a-tocopherol, β-tocopherol, γ-tocopherol, and δ-tocopherol. 4. The emulsion of claim 1 , wherein the at least one tocopherol is present in an amount of 200 to 800 ppm. 5. The emulsion of claim 1 , wherein the rosemary extract is present in an amount of 500 to 4000 ppm. 6. A food, a feed or a personal care product consisting essentially of the emulsion of claim 1 .
Assignees
Inventors
Classifications
Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof · CPC title
General cosmetic use · CPC title
Magnoliopsida [dicotyledons] · CPC title
Collagen; Gelatin; Keratin; Derivatives or degradation products thereof · CPC title
Emulsified foodstuffs · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9579301B2 cover?
- The present invention relates to an emulsion of an oil composition comprising docasoahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which is characterized in that the emulsion is essentially free from ascorbyl palmitate.
- Who is the assignee on this patent?
- Dsm Ip Assets Bv
- What technology area does this patent fall under?
- Primary CPC classification A61K31/202. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).